Verition Fund Management’s CARGO Therapeutics CRGX Stock Holding History
Bought
Maintained
Sold
Other funds holding CRGX
SB
MAP
CAM
TCM
NI
TGV
TGV
Verition Fund Management's CRGX Position: Q2 2025 in Review
Verition Fund Management sold out of CARGO Therapeutics (CRGX) in Q2 2025, closing a stake of 91,405 shares — an estimated $372K sold.
Verition Fund Management first reported a position in CRGX in Q2 2024 and held it in 3 quarters. The position peaked at $566K in Q4 2024. 116 funds tracked by Wall St. Rank hold CRGX as of Q2 2025.
- Verition Fund Management reported no remaining CARGO Therapeutics position as of Q2 2025 after selling out during the quarter.
- Verition Fund Management sold 91,405 CARGO Therapeutics shares in Q2 2025, an estimated $372K.
- Verition Fund Management first reported a position in CARGO Therapeutics in Q2 2024 and held it in 3 quarters.
- Verition Fund Management's CARGO Therapeutics position peaked at $566K in Q4 2024.
- 116 funds tracked by Wall St. Rank held CARGO Therapeutics as of Q2 2025.
Based on Verition Fund Management's 13F filing for Q2 2025, filed 14 Aug 2025.